Evidence map›Paper›PMID 26728740›Full record

ArticleDoklady. Biochemistry and biophysics2015

Anion-selective channelrhodopsin expressed in neuronal cell culture and in vivo in murine brain: Light-induced inhibition of generation of action potentials.

D A Dolgikh, A Yu Malyshev, S V Salozhin, O V Nekrasova, L E Petrovskaya, M V Roshchin, A A Borodinova, T B Feldman, P M Balaban, M P Kirpichnikov and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady. Biochemistry and biophysics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. New era of optogenetics: from the central to peripheral nervous system.Critical reviews in biochemistry and molecular biology · 2020
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

D A DolgikhPirogov Russian National Research Medical University, Moscow, Russia.
A Yu MalyshevInstitute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, Moscow, Russia.
S V SalozhinInstitute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, Moscow, Russia.
O V NekrasovaMoscow State University, Faculty of Biology, Moscow, Russia.
L E PetrovskayaPirogov Russian National Research Medical University, Moscow, Russia.
M V RoshchinInstitute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, Moscow, Russia.
A A BorodinovaInstitute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, Moscow, Russia.
T B FeldmanMoscow State University, Faculty of Biology, Moscow, Russia.
P M BalabanInstitute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, Moscow, Russia.
M P KirpichnikovMoscow State University, Faculty of Biology, Moscow, Russia.
M A OstrovskyMoscow State University, Faculty of Biology, Moscow, Russia. ostrovsky3535@mail.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anionic channelrhodopsin slow ChloC was expressed in the culture of nerve cells and in vivo in mouse brain. We demonstrated ability of slow ChloC to suppress effectively the activity of the neuron in response to the illumination with the visible light. It has been shown for a first time that slow ChloC works equally efficiently in both neuronal culture and in the whole brain being expressed in vivo. Thus, slow ChloC could be considered as an effective optogenetic tool capable in response to light stimulation to inhibit the generation of action potentials in the neuron.

Indexed as

Action PotentialsAnimalsBrainCells, CulturedLightMiceNeuronsOptogeneticsRhodopsinRhodopsin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.